SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer
Clinical trial NCT07662811 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662811
- Sponsor
- Shanghai Chest Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-31
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.